Subtype selective substrates for histone deacetylases

被引:110
作者
Heltweg, B
Dequiedt, F
Marshall, BL
Branch, C
Yoshida, M
Nishino, N
Verdin, E
Jung, M
机构
[1] Univ Munster, Dept Pharmaceut & Med Chem, D-48149 Munster, Germany
[2] FUSAGx, Mol & Cellular Biol Unit, B-5030 Gembloux, Belgium
[3] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA
[4] RIKEN, Chem Genet Lab, Wako, Saitama 3510198, Japan
[5] Kyushu Inst Technol, Dept Appl Chem, Tabata Ku, Kitakyushu, Fukuoka 8048550, Japan
关键词
D O I
10.1021/jm0497592
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To probe the steric requirements for deacylation, we synthesized lysine-derived small molecule substrates and examined structure -reactivity relationships with various histone deacetylases. Rat liver, human HeLa, and human recombinant class I and II histone deacetylases (HDACs) as well as human recombinant NAD(+)-dependent SIRT1 (class III enzyme) were used in these studies. A benzyloxycarbonyl substituent on the alpha-amino group yielded the highest conversion rates. Replacing the epsilon-acetyl group with larger lipophilic acyl substituents led to a pronounced decrease in conversion by class I and II enzymes; the class III enzyme displayed a greater tolerance. Incubations with recombinant FLAG-tagged human HDACs 1, 3, and 6 showed a distinct subtype selectivity among small molecule substrates. The subtype selectivity of HDAC inhibitors could be predicted with these substrates and an easily obtainable mixture of HDAC subtypes.
引用
收藏
页码:5235 / 5243
页数:9
相关论文
共 37 条
  • [1] AN EXPERIMENTAL APPROACH TO LONG-LASTING HYPOTENSIVE ELEDOISIN-LIKE PEPTIDES
    BERNARDI, L
    DECASTIG.R
    FREGNAN, GB
    GLASSER, AH
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1967, 19 (02) : 95 - &
  • [2] Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: Synthesis and antiproliferative evaluation
    Bouchain, G
    Delorme, D
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (22) : 2359 - 2372
  • [3] Induction of human γ globin gene expression by histone deacetylase inhibitors
    Cao, H
    Stamatoyannopoulos, G
    Jung, M
    [J]. BLOOD, 2004, 103 (02) : 701 - 709
  • [4] Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
    Finnin M.S.
    Donigian J.R.
    Cohen A.
    Richon V.M.
    Rifkind R.A.
    Marks P.A.
    Breslow R.
    Pavletich N.P.
    [J]. Nature, 1999, 401 (6749) : 188 - 193
  • [5] Enzymatic activity associated with class IIHDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR
    Fischle, W
    Dequiedt, F
    Hendzel, MJ
    Guenther, MG
    Lazar, MA
    Voelter, W
    Verdin, E
    [J]. MOLECULAR CELL, 2002, 9 (01) : 45 - 57
  • [6] A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p
    Fischle, W
    Emiliani, S
    Hendzel, MJ
    Nagase, T
    Nomura, N
    Voelter, W
    Verdin, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (17) : 11713 - 11720
  • [7] Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo
    Fischle, W
    Dequiedt, F
    Fillion, M
    Hendzel, MJ
    Voelter, W
    Verdin, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) : 35826 - 35835
  • [8] Fournel M, 2002, CANCER RES, V62, P4325
  • [9] Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin
    Furumai, R
    Komatsu, Y
    Nishino, N
    Khochbin, S
    Yoshida, M
    Horinouchi, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) : 87 - 92
  • [10] The human histone deacetylase family
    Gray, SG
    Ekström, TJ
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 262 (02) : 75 - 83